j.silva
TL2 · Tours
Contributes reviews on supplier material. Based in Tours.
Joined 14 February 2025 · last posted 10d
80 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #64 · Practice › Interactions · 18 Jul 2026 · 0 likes Narrowing post #63, because the general version has more than one answer. Common supplements has been discussed here with more heat than it deserves, mostly because two…
-
Blinding yourself: practical methods and their limits Replied, post #43 · Research Methods › N-of-1 designs · 16 Jul 2026 · 0 likes Blinding yourself is harder than it sounds and is not impossible. Somebody else preparing labelled containers is the usual approach and it requires a second person you…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #24 · Access › Insurance & coverage · 13 Jul 2026 · 6 likes Worth separating two things that post #20 runs together. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can…
-
Insurance and replacement policies, compared Replied, post #84 · Sourcing › Logistics · 13 Jul 2026 · 7 likes Post #80 put the caveat in the right place and I want to underline it. Practical note on insurance and replacement policies: write down what you expect before you look.…
-
Restarting after a long gap: what the labelling implies Replied, post #23 · Practice › Dosing & titration · 13 Jul 2026 · 0 likes Post #22 is the version of this I will quote in future. One addition. Research-use-only material is not a licensed product and no labelling covers it. Everything in…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #19 · Sourcing › Logistics · 12 Jul 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Private prescribing in the UK: what is actually involved Replied, post #59 · Regional › UK & Ireland · 8 Jul 2026 · 16 likes Answering the question post #55 raises rather than the one it answers. Source for the private prescribing figure, since it was asked for. It is in the discussion rather…
-
Follow-up: Signs of dehydration worth acting on Replied, post #15 · Safety › Adverse events · 6 Jul 2026 · 3 likes What I would want before treating Signs of dehydration worth acting as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #9 · Nutrition & Training › Protein & intake · 26 Jun 2026 · 7 likes I read post #5 twice before replying, because I had assumed the opposite. Protein density versus volume is well covered in the tag pages, and the older discussions are…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #11 · Analytics › Home & field testing · 25 Jun 2026 · 14 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #24 · Outcomes › Body composition · 20 Jun 2026 · 4 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly. That…
-
A 40-week log with the measurement method stated — what changed since Replied, post #8 · Outcomes › Progress reports · 16 Jun 2026 · 10 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #30 · Sourcing › Red flags · 4 Jun 2026 · 5 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…
-
[2026 update] Second opinions: how to seek one without burning the first Started this topic · Clinical › Prescriber conversations · 1 Jun 2026 · 10 likes On the subject in the title: Second opinions: how to seek one without burning the first Working notes rather than a conclusion. Two things I would like separated before…
-
Five questions in one post gets you one answer — how to split them Replied, post #85 · Start Here › How to Ask · 19 May 2026 · 2 likes Agreed on all of that, and I have nothing to add to it.
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #18 · Compounds › Retatrutide · 26 Apr 2026 · 3 likes Post #15 answers the question as asked. The question underneath it is different. Heart rate increased in a dose-dependent way in the phase 2 work. That is not a…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #91 · Practice › Interactions · 23 Apr 2026 · 0 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
What a good consultation looks like from the other side Replied, post #32 · Clinical › Prescriber conversations · 15 Apr 2026 · 2 likes Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable. The reasoning is…
-
Spike-and-recover accuracy for a peptide assay Replied, post #16 · Analytics › Method validation · 7 Apr 2026 · 10 likes Post #13 is right about the mechanism and I think understates the practical bit. The limit of quantitation determines what the impurity table can honestly contain.…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #54 · Analytics › Mass spectrometry · 4 Apr 2026 · 3 likes An acylated peptide has a mass that reflects the modification, so comparing against the mass of the unmodified backbone gives a mismatch that is not an error. Written…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #122 · Pharmacology › Pharmacokinetics · 2 Apr 2026 · 19 likes Half-life has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #19 · Outcomes › Progress reports · 15 Mar 2026 · 22 likes That is the distinction I keep failing to hold on to. Written down now.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #144 · Analytics › COA interpretation · 3 Mar 2026 · 4 likes Worth separating two things that post #143 runs together. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #4 · Analytics › Impurities & related substances · 19 Feb 2026 · 7 likes Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has characterised its own process. That is a meaningful…
-
Reused chromatograms across lots: how to spot it Replied, post #21 · Analytics › COA interpretation · 18 Feb 2026 · 6 likes Bookmarking this. I will come back when I have something worth adding.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #38 · Pharmacology › Pharmacokinetics · 10 Feb 2026 · 0 likes Taking post #35 at face value and following it one step further. Where the Washout reasoning breaks down for me is the step from the group result to the individual…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #44 · Evidence › Trials · 7 Feb 2026 · 2 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
[2026 update] What a purity-only report leaves out Replied, post #12 · Sourcing › Independent verification · 30 Jan 2026 · 6 likes Purity-only is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Reading an interaction checker output critically Replied, post #104 · Practice › Interactions · 28 Jan 2026 · 2 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #18 · Practice › Reconstitution · 27 Jan 2026 · 0 likes Post #14 and I disagree about the size of the effect, not about the direction. The strongest argument against my own position on Foaming during reconstitution, stated…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #21 · Clinical › Special populations · 22 Jan 2026 · 33 likes For anyone finding this later: the short answer on pregnancy and pregnancy planning is that it depends on one thing, and the rest of the thread is people identifying…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #12 · Evidence › Trials · 21 Jan 2026 · 2 likes The version of Non-inferiority margins that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #6 · Clinical › Special populations · 20 Jan 2026 · 0 likes Small methodological point on Pregnancy and pregnancy planning: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
-
Cost per delivered dose, which is the number that matters Replied, post #40 · Access › Pricing · 18 Jan 2026 · 0 likes Nothing here is financial advice and none of it is a route to a transaction. It is worth stating the boring hypothesis before the interesting one.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #12 · Sourcing › Logistics · 25 Dec 2025 · 27 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. I have written this out at length because the short…
-
Substitution between formats during a shortage Replied, post #111 · Access › Shortages · 7 Dec 2025 · 25 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Publishing an inconvenient result: a case study — the long version Replied, post #60 · Sourcing › Independent verification · 5 Dec 2025 · 0 likes Coming back to post #56, because the follow-up matters more than the original answer. What I can speak to on Publishing an inconvenient result is narrow, so I will keep…
-
The headache that turns out to be dehydration Replied, post #75 · Nutrition & Training › Hydration & electrolytes · 29 Nov 2025 · 15 likes My understanding of headache is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Comparing my trajectory with the trial curves, carefully Replied, post #80 · Outcomes › Progress reports · 23 Nov 2025 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. The short version is the first…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #46 · Compounds › Oral incretins · 16 Nov 2025 · 5 likes Right, and stated more narrowly than I would have dared to state it.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #71 · Start Here › How to Ask · 8 Nov 2025 · 15 likes Building on post #68 rather than restating it. "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you…
-
Follow-up: What a seizure notice actually says Replied, post #36 · Sourcing › Logistics · 27 Oct 2025 · 23 likes Thank you for the correction. I would rather find out here than later.
-
What a purity-only report leaves out Replied, post #58 · Sourcing › Independent verification · 24 Oct 2025 · 16 likes That is clearer than the version I had in my head. Thank you.
-
Where impurities in solid-phase peptide synthesis come from Replied, post #12 · Analytics › Impurities & related substances · 8 Oct 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #81 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 0 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #50 · Compounds › Secretagogues & GH axis · 21 Sep 2025 · 20 likes Where I part company with post #46, and it is a narrow parting. Effects reported at the level of appetite are the most consistently described and the most…
-
What this community means by "a source", in practical terms Replied, post #109 · Start Here › Welcome · 11 Sep 2025 · 14 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #101 · Data & Tools › Datasets · 10 Sep 2025 · 0 likes Narrowing post #98, because the general version has more than one answer. Combining results from different testing services into one column loses information that…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #62 · Analytics › HPLC & UHPLC · 7 Sep 2025 · 2 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #106 · Practice › Reconstitution · 15 Aug 2025 · 13 likes Good question, well framed, and I would like to see it answered properly.
-
A ten-fold dose error caught before injection Replied, post #73 · Devices › Syringes & needles · 29 Jul 2025 · 2 likes Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger tip is the reading. Parallax error (wrong angle) is a…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #94 · Practice › Storage & stability · 23 Jul 2025 · 3 likes Everything in post #90 holds. The case it does not cover is the one I have. Before the thread moves on from published stability data actually covers — what is the…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #5 · Evidence › Meta-analyses · 16 Jun 2025 · 3 likes Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity analysis excluding the weakest studies is the minimum. That is…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #13 · Clinical › Bloodwork · 11 Jun 2025 · 27 likes Two sentences on Lipase elevation without symptoms and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
Coverage for the indication versus for the drug Replied, post #79 · Access › Insurance & coverage · 24 May 2025 · 16 likes Adding the measurement that post #78 says would settle it. What I can speak to on coverage is narrow, so I will keep it narrow rather than generalising from it. Beyond…
-
Lipase elevation without symptoms: the interpretation problem — a second dataset Replied, post #4 · Clinical › Bloodwork · 24 May 2025 · 20 likes Filing a mild objection to the consensus on Lipase elevation without symptoms. Mild because I might be wrong; an objection because nobody has addressed the case that…
-
Second pass at: Designing a personal experiment that could change your mind Replied, post #40 · Research Methods › N-of-1 designs · 21 May 2025 · 0 likes A photograph or a device reading is a harder record than a recollection, and where one is available it should be the record. I have kept the units in throughout, for…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #26 · Evidence › Trials · 16 May 2025 · 2 likes Post #22 put the caveat in the right place and I want to underline it. Sample size calculations has a well-known answer and a correct answer, and the interesting work…
-
Second pass at: Designing a personal experiment that could change your mind Started this topic · Research Methods › N-of-1 designs · 15 May 2025 · 10 likes Second pass at: Designing a personal experiment that could change your mind Writing it up because I had to work it out twice and would rather nobody else did. The…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #24 · Practice › Administration · 2 May 2025 · 24 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Fibre intake when total intake falls, and the constipation link Replied, post #56 · Nutrition & Training › Protein & intake · 20 Apr 2025 · 10 likes Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows from that as much as from the mechanism. Filing this under…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #29 · Clinical › Comorbidities · 8 Mar 2025 · 4 likes Adding the measurement that post #28 says would settle it. The practical value of this subcategory is helping somebody frame the question they take to an appointment,…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #24 · Compounds › Other compounds · 21 Feb 2025 · 30 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
An orphaned page with no inbound links Replied, post #9 · Meta › Wiki maintenance · 16 Feb 2025 · 17 likes Review dates: each maintained page has a review date (the date by which it should be checked). If a page is past its review date, flagging it here alerts the…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #10 · Wellbeing › Mental health · 27 Jan 2025 · 0 likes Expectations set by other people's reported trajectories are a documented source of distress, and the trajectories posted are not representative. The short version is…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #29 · Compounds › Oral incretins · 7 Jan 2025 · 0 likes Where I part company with post #25, and it is a narrow parting. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #8 · Practice › Reconstitution · 5 Jan 2025 · 30 likes Speaking only to 5 mg vial as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the…
-
Coming back to: When to suspect the method rather than the sample Replied, post #86 · Analytics › Method validation · 17 Dec 2024 · 2 likes Taking post #83 at face value and following it one step further. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #44 · Nutrition & Training › Protein & intake · 8 Dec 2024 · 13 likes Post #40 and I disagree about the size of the effect, not about the direction. Protein supplements: whey, casein, and plant-based protein powders can help hit targets…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #14 · Devices › Cold chain · 26 Nov 2024 · 0 likes No disagreement from me. Posting only so the question does not look ignored.
-
Why "any advice?" is the least effective ending for a post Replied, post #59 · Start Here › How to Ask · 21 Nov 2024 · 8 likes Building on post #56 rather than restating it. Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #24 · Nutrition & Training › Resistance training · 15 Nov 2024 · 5 likes Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity can help with recovery and sometimes reveal strength gains that got obscured by…
-
Time to steady state after a dose increase Replied, post #56 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 11 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #36 · Wellbeing › Mental health · 17 Oct 2024 · 11 likes Post #32 put the caveat in the right place and I want to underline it. Something worth flagging about Food noise: the strongest-sounding claims in this thread are the…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #7 · Compounds › Oral incretins · 26 Aug 2024 · 0 likes Reading this orforglipron thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Progressive overload when the scale is falling — one year on Replied, post #5 · Nutrition & Training › Resistance training · 25 Aug 2024 · 23 likes Worth separating two things that the opening post runs together. The reports here that state the programme, the load and the timeframe are useful. The ones that state…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #11 · Sourcing › Independent verification · 22 Aug 2024 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Circumference measurements as a poor man's composition estimate Replied, post #78 · Outcomes › Body composition · 18 Aug 2024 · 3 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #12 · Compounds › Semaglutide · 18 Aug 2024 · 31 likes I have no financial interest in anything named in this thread and I want to say so before I comment on c-cell question, because it is the sort of subject where it…
-
Request: a diff view for wiki revisions Replied, post #6 · Meta › Feature requests · 18 Aug 2024 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.